Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-30T08:23:58.931Z Has data issue: false hasContentIssue false

Chapter 3 - The Costs and Burdens of Psychogenic Nonepileptic Seizures in Context

PNES and Other Conversion Disorders

from Section 1 - Recognition, Diagnosis, and Impact of Nonepileptic Seizures

Published online by Cambridge University Press:  18 May 2018

By
James C. Hamilton ,
Roy C. Martin ,
Jon Stone  and
Ian Sherwood
Edited by
W. Curt LaFrance, Jr  and
Steven C. Schachter
W. Curt LaFrance, Jr
Affiliation:
Brown Medical School, Providence
Steven C. Schachter
Affiliation:
Beth Israel Deaconess Medical Center, Boston
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Gates and Rowan's Nonepileptic Seizures , pp. 31 - 43
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. (DSM-5). Washington, DC: American Psychiatric Association, 2013.Google Scholar
Buck, CJ. The International Classification of Diseases, 2014 ICD-10-CM Draft edition. St. Louis, MO: Saunders Elsevier, 2013.Google Scholar
United States Health Care Financing Administration. The International Classification of Diseases, 9th Revision, Clinical Modification: ICD-9-CM, 2nd edn. Washington, DC: US Dept. of Health and Human Services, Public Health Service; for sale by the Supt. of Docs., US GPO, 1980.Google Scholar
Dixit, R, Popescu, A, Bagic, A, Ghearing, G, Hendrickson, R. Medical comorbidities in patients with psychogenic nonepileptic spells (PNES) referred for video-EEG monitoring. Epilepsy Behav 2013;28:137–140.Google Scholar
Ettinger, AB, Devinsky, O, Weisbrot, DM, Goyal, A, Shashikumar, S. Headaches and other pain symptoms among patients with psychogenic non-epileptic seizures. Seizure 1999;8:424–426.CrossRefGoogle ScholarPubMed
Yilmaz, U, Serdaroglu, A, Gurkas, E, Hirfanoglu, T, Cansu, A. Childhood paroxysmal nonepileptic events. Epilepsy Behav 2013;27:124–129.Google Scholar
Kaplan, MJ, Dwivedi, AK, Privitera, MD, et al. Comparisons of childhood trauma, alexithymia, and defensive styles in patients with psychogenic non-epileptic seizures vs. epilepsy: implications for the etiology of conversion disorder. J Psychosom Res 2013;75:142–146.Google Scholar
Hovorka, J, Nezadal, T, Herman, E, Nemcova, I, Bajacek, M. Psychogenic non-epileptic seizures, prospective clinical experience: diagnosis, clinical features, risk factors, psychiatric comorbidity, treatment outcome. Epileptic Disord 2007;9 (Suppl 1):S52–58.Google Scholar
Scevola, L, Teitelbaum, J, Oddo, S, et al. Psychiatric disorders in patients with psychogenic nonepileptic seizures and drug-resistant epilepsy: a study of an Argentine population. Epilepsy Behav 2013;29:155–160.CrossRefGoogle ScholarPubMed
Karakis, I, Montouris, GD, Piperidou, C, et al. Patient and caregiver quality of life in psychogenic non-epileptic seizures compared to epileptic seizures. Seizure 2014;23:47–54.Google Scholar
Hoedeman, R, Blankenstein, AH, Krol, B, Koopmans, PC, Groothoff, JW. The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge. J Occup Rehab 2010;20:264–273.Google Scholar
Silverman, S, Dukes, EM, Johnston, SS, et al. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin 2009;25:829–840.CrossRefGoogle ScholarPubMed
Brown, RJ, Bouska, JF, Frow, A, et al. Emotional dysregulation, alexithymia, and attachment in psychogenic nonepileptic seizures. Epilepsy Behav 2013;29:178–183.Google Scholar
Bewley, J, Murphy, PN, Mallows, J, Baker, GA. Does alexithymia differentiate between patients with nonepileptic seizures, patients with epilepsy, and nonpatient controls? Epilepsy Behav 2005;7:430–437.Google Scholar
Lally, N, Spence, W, McCusker, C, Craig, J, Morrow, J. Psychological processes and histories associated with nonepileptic versus epileptic seizure presentations. Epilepsy Behav 2010;17:360–365.Google Scholar
Holman, N, Kirkby, A, Duncan, S, Brown, RJ. Adult attachment style and childhood interpersonal trauma in non-epileptic attack disorder. Epilepsy Res 2008;79:84–89.CrossRefGoogle ScholarPubMed
Stone, J, Binzer, M, Sharpe, M. Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy. J Psychosom Res 2004;57:541–547.CrossRefGoogle ScholarPubMed
Hilderink, PH, Collard, R, Rosmalen, JG, Oude, Voshaar RC. Prevalence of somatoform disorders and medically unexplained symptoms in old age populations in comparison with younger age groups: a systematic review. Ageing Res Rev 2013;12:151–156.Google Scholar
Fink, P, Hansen, MS, Oxhoj, M-L. The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 2004;56:413–418.Google Scholar
De Waal, MWM, Arnold, IA, Eekhof, JAH, Van Hemert, AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004;184:470–476.Google Scholar
Escobar, JI, Waitzkin, H, Silver, RC, Gara, M, Holman, A. Abridged somatization: a study in primary care. Psychosom Med 1998;60:466–472.Google Scholar
Kroenke, K, Spitzer, RL, deGruy, FV, et al. Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 1997;54:352–358.CrossRefGoogle ScholarPubMed
Verhaak, PFM, Meijer, SA, Visser, AP, Wolters, G. Persistent presentation of medically unexplained symptoms in general practice. Fam Pract 2006; 23:414–420.CrossRefGoogle ScholarPubMed
Dimsdale, JE, Creed, F, Escobar, J, et al. Somatic symptom disorder: an important change in DSM. J Psychosom Res 2013;75:223–228.CrossRefGoogle ScholarPubMed
Swanson, LM, Hamilton, JC, Feldman, MD. Physician-based estimates of medically unexplained symptoms: a comparison of four case definitions. Fam Pract 2010;27:487–493.CrossRefGoogle ScholarPubMed
Johnston, S, Brenu, EW, Staines, D, Marshall-Gradisnik, S. The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis. Clin Epidemiol 2013;5:105–110.Google Scholar
Bates, DW, Schmitt, W, Buchwald, D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993;153:2759–2765.CrossRefGoogle Scholar
Branco, JC, Bannwarth, B, Failde, I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010;39:448–453.CrossRefGoogle ScholarPubMed
Wolfe, F, Brahler, E, Hinz, A, Hauser, W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 2013;65:777–785.CrossRefGoogle ScholarPubMed
Perrot, S, Vicaut, E, Servant, D, Ravaud, P. Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: the DEFI study (Determination of Epidemiology of FIbromyalgia). BMC Musculoskelet Disord 2011;12:224.Google Scholar
Ablin, JN, Oren, A, Cohen, S, et al. Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol 2012;30:39–43.Google ScholarPubMed
Lawrence, RC, Felson, DT, Helmick, CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 2008;58:26–35.CrossRefGoogle ScholarPubMed
Lovell, RM, Ford, AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712–721.e714.CrossRefGoogle ScholarPubMed
Fischer, S, Gaab, J, Ehlert, U, Nater, UM. Prevalence, overlap, and predictors of functional somatic syndromes in a student sample. Int J Behav Med 2013;20:184–193.Google Scholar
Katsinelos, P, Lazaraki, G, Kountouras, J, et al. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Eur J Gastroenterol Hepatol 2009;21:183–189.CrossRefGoogle ScholarPubMed
Wessely, S, Chalder, T, Hirsch, S, Wallace, P, Wright, D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87:1449–1455.Google Scholar
Lowe, B, Mundt, C, Herzog, W, et al. Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. Psychopathology 2008;41:4–9.Google Scholar
Katon, W, Sullivan, M, Walker, E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med 2001;134:917–925.Google Scholar
Barsky, AJ, Orav, EJ, Bates, DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62:903–910.Google Scholar
Fink, P. Surgery and medical treatment in persistent somatizing patients. J Psychosom Res 1992;36:439–447.Google Scholar
Doshi, JA, Cai, Q, Buono, JL, et al. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population. J Manag Care Pharm 2014;20:382–390.Google Scholar
Canavan, C, West, J, Card, T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023–1034.Google Scholar
Cai, Q, Buono, JL, Spalding, WM, et al. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population. J Med Econ 2014;17:148–158.Google Scholar
Lin, JM, Resch, SC, Brimmer, DJ, et al. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Eff Resource Alloc 2011;9:1.CrossRefGoogle ScholarPubMed
Knight, T, Schaefer, C, Chandran, A, et al. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res 2013;5:171–180.Google Scholar
Chandran, A, Schaefer, C, Ryan, K, et al. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Managed Care Pharm 2012;18:415–426.Google Scholar
Sabes-Figuera, R, McCrone, P, Hurley, M, et al. The hidden cost of chronic fatigue to patients and their families. BMC Health Serv Res 2010;10:56.Google Scholar
Kleinman, N, Harnett, J, Melkonian, A, et al. Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med 2009;51:1384–1393.CrossRefGoogle ScholarPubMed
Nurmi, E, Haapamaki, J, Paavilainen, E, et al. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013;48:51–57.CrossRefGoogle ScholarPubMed
Wolfe, F, Michaud, K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. J Rheumatol 2004;31:695–700.Google Scholar
Wolfe, F, Michaud, K, Li, T, Katz, RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 2010;37:296–304.Google Scholar
Zimmerman, J. Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms. Dig Dis Sci 2003;48:743–749.Google Scholar
Pace, F, Molteni, P, Bollani, S, et al. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol 2003;38:1031–1038.Google Scholar
Walker, EA, Gelfand, AN, Gelfand, MD, Katon, WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995;25:1259–1267.Google Scholar
Walker, JG, Littlejohn, GO. Measuring quality of life in rheumatic conditions. Clin Rheumatol 2007;26:671–673.CrossRefGoogle ScholarPubMed
Carson, AJ, Ringbauer, B, Stone, J, et al. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 2000;68:207–210.CrossRefGoogle Scholar
Nimnuan, C, Hotopf, M, Wessely, S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001;51:361–367.Google Scholar
Snijders, TJ, de Leeuw, FE, Klumpers, UM, Kappelle, LJ, van Gijn, J. Prevalence and predictors of unexplained neurological symptoms in an academic neurology outpatient clinic–an observational study. J Neurol 2004;251:66–71.Google Scholar
Parry, AM, Murray, B, Hart, Y, Bass, C. Audit of resource use in patients with non-organic disorders admitted to a UK neurology unit. J Neurol Neurosurg Psychiatry 2006;77:1200–1201.Google Scholar
Stone, J, Carson, A, Duncan, R, et al. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain 2009;132:2878–2888.CrossRefGoogle ScholarPubMed
Fink, P, Steen, HM, Sondergaard, L. Somatoform disorders among first-time referrals to a neurology service. Psychosomatics 2005;46:540–548.Google Scholar
Stone, J, Carson, A, Duncan, R, et al. Who is referred to neurology clinics? – the diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010;112:747–751.CrossRefGoogle ScholarPubMed
Perkin, GD. An analysis of 7836 successive new outpatient referrals. J Neurol Neurosurg Psychiatry 1989;52:447–448.Google Scholar
Schiffer, RB. Psychiatric aspects of clinical neurology. Am J Psychiatry 1983;140:205–207.Google ScholarPubMed
Marsden, CD. Hysteria – a neurologist's view. Psychol Med 1986;16:277–288.Google Scholar
Lempert, T, Dieterich, M, Huppert, D, Brandt, T. Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurol Scand 1990;82:335–340.Google Scholar
Schofield, A, Duane, MM. Neurologic referrals to a psychiatric consultation-liaison service. A study of 199 patients. Gen Hosp Psychiatry 1987;9:280–286.Google Scholar
Mace, CJ, Trimble, MR. Ten-year prognosis of conversion disorder. Br J Psychiatry 1996;169:282–288.Google Scholar
Carson, A, Stone, J, Hibberd, C, et al. Disability, distress and unemployment in neurology outpatients with symptoms ‘unexplained by organic disease’. J Neurol Neurosurg Psychiatry 2011;82:810–813.Google Scholar
Carson, AJ, Stone, J, Warlow, C, Sharpe, M. Patients whom neurologists find difficult to help. J Neurol Neurosurg Psychiatry 2004;75:1776–1778.Google Scholar
Stone, J, Smyth, R, Carson, A, et al. Systematic review of misdiagnosis of conversion symptoms and “hysteria”. Br Med J 2005;331:989.Google Scholar
Benbadis, SR. A spell in the epilepsy clinic and a history of “chronic pain” or “fibromyalgia” independently predict a diagnosis of psychogenic seizures. Epilepsy Behav 2005;6:264–265.Google Scholar
Duncan, R, Razvi, S, Mulhern, S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 2011;20:308–311.Google Scholar
Driver-Dunckley, E, Stonnington, CM, Locke, DE, Noe, K. Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important? Psychosomatics 2011;52:337–345.Google Scholar
Dworetzky, B, Mortati, K, Rossetti, A, et al. Clinical characteristics of psychogenic nonepileptic seizure status in the long-term monitoring unit. Epilepsy Behav 2006;9:335–338.Google Scholar
de Wet, CJ, Mellers, JD, Gardner, WN, Toone, BK. Pseudoseizures and asthma. J Neurol Neurosurg Psychiatry 2003;74:639–641.CrossRefGoogle ScholarPubMed
Lempert, T, Schmidt, D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 1990;237:35–38.CrossRefGoogle ScholarPubMed
Bowman, ES, Markand, ON. Diagnosis and treatment of pseudoseizures. Psychiatric Ann 2005;35:306–316.Google Scholar
Meierkord, H, Will, B, Fish, D, Shorvon, S. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology 1991;41:1643–1646.CrossRefGoogle ScholarPubMed
Pakalnis, A, Paolicchi, J. Frequency of secondary conversion symptoms in children with psychogenic nonepileptic seizures. Epilepsy Behav 2003;4:753–756.Google Scholar
Crimlisk, HL, Bhatia, K, Cope, H, et al. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. Br Med J 1998;316:582–586.CrossRefGoogle ScholarPubMed
Reuber, M, House, AO, Pukrop, R, Bauer, J, Elger, CE. Somatization, dissociation and general psychopathology in patients with psychogenic non-epileptic seizures. Epilepsy Res 2003;57:159–167.Google Scholar
Reuber, M, Howlett, S, Khan, A, Grunewald, RA. Non-epileptic seizures and other functional neurological symptoms: predisposing, precipitating, and perpetuating factors. Psychosomatics 2007;48:230–238.Google Scholar
Magee, JA, Burke, T, Delanty, N, Pender, N, Fortune, GM. The economic cost of nonepileptic attack disorder in Ireland. Epilepsy Behav 2014;33:45–48.Google Scholar
Ahmedani, BK, Peterson, EL, Wells, KE, Lanfear, DE, Williams, LK. Policies and events affecting prescription opioid use for non-cancer pain among an insured patient population. Pain Physician 2014;17:205–216.Google Scholar
Duncan, R, Graham, CD, Oto, M. Outcome at 5–10 years in psychogenic nonepileptic seizures: what patients report vs. what family doctors report. Epilepsy Behav 2014;37C:71–74.Google Scholar
Strzelczyk, A, Reese, JP, Dodel, R, Hamer, HM. Cost of epilepsy: a systematic review. Pharmaco Economics 2008;26:463–476.Google Scholar
Begley, CE, Beghi, E. The economic cost of epilepsy: a review of the literature. Epilepsia 2002;43:3–9.Google Scholar
Begley, CE, Annegers, JF, Lairson, DR, Reynolds, TF, Hauser, WA. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994;35:1230–1243.Google Scholar
Ahmedani, BK, Osborne, J, Nerenz, DR, et al. Diagnosis, costs, and utilization for psychogenic non-epileptic seizures in a US health care setting. Psychosomatics 2013;54:28–34.Google Scholar
Jirsch, JD, Ahmed, SN, Maximova, K, Gross, DW. Recognition of psychogenic nonepileptic seizures diminishes acute care utilization. Epilepsy Behav 2011;22:304–307.Google Scholar
Razvi, S, Mulhern, S, Duncan, R. Newly diagnosed psychogenic nonepileptic seizures: health care demand prior to and following diagnosis at a first seizure clinic. Epilepsy Behav 2012;23:7–9.Google Scholar
Duncan, R, Graham, CD, Oto, M, et al. Primary and secondary care attendance, anticonvulsant and antidepressant use and psychiatric contact 5–10 years after diagnosis in 188 patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2014;85:954–958.Google Scholar
Oto, M, Espie, C, Pelosi, A, Selkirk, M, Duncan, R. The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures. J Neurol Neurosurg Psychiatry 2005;76:1682–1685.Google Scholar
Martin, R, Gilliam, F, Kilgore, M, Faught, E, Kuzniecky, R. Improved health care resource utilization following video-EEG confirmed diagnosis of nonepileptic psychogenic seizures. Seizure 1998;7:385–390.CrossRefGoogle ScholarPubMed
Finlayson, O, Mirsattari, SM, Derry, P, et al. Economic impact of non-epileptic seizures on the health care system and the importance of their early diagnosis and treatment. Neurology 2008;70:A69-A70.Google Scholar
Hamilton, J, Martin, R, Stone, J, Worley, C. The burden of psychogenic nonepileptic seizures (PNES) in context: PNES and medically unexplained symptoms. In: Schachter SC, LaFrance WC Jr., Gates and Rowan's Nonepileptic Seizures, 3rd edn. New York: Cambridge University Press, 2010:27–37.Google Scholar
Reuber, M, Elger, CE. Psychogenic nonepileptic seizures: review and update. Epilepsy Behav 2003;4:205–216.Google Scholar
Dworetzky, BA, Mortati, KA, Rossetti, AO, et al. Clinical characteristics of psychogenic nonepileptic seizure status in the long-term monitoring unit. Epilepsy Behav 2006;9:335–338.Google Scholar
Hantke, NC, Doherty, MJ, Haltiner, AM. Medication use profiles in patients with psychogenic nonepileptic seizures. Epilepsy Behav 2007;10:333–335.Google Scholar
Bodde, NM, Janssen, AM, Theuns, C, et al. Factors involved in the long-term prognosis of psychogenic nonepileptic seizures. J Psychosom Res 2007;62:545–551.Google Scholar
Oto, M, Espie, C, Pelosi, A, Selkirk, M, Duncan, R. The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures. J Neurol Neurosurg Psychiatry 2005;76:1682–1685.Google Scholar
Reuber, M, Pukrop, R, Bauer, J, et al. Outcome in psychogenic nonepileptic seizures: 1 to 10 year follow-up in 164 patients. Ann Neurol 2003;53:305–311.Google Scholar
Binder, LM, Salinsky, MC. Psychogenic nonepileptic seizures. Neuropsychol Rev 2007;17:405–412.CrossRefGoogle ScholarPubMed
Reuber, M. Psychogenic nonepileptic seizures: answers and questions. Epilepsy Behav 2008;12:622–635.Google Scholar
So, EL, Schauble, BS. Ictal asomatognosia as a cause of epileptic falls: simultaneous video, EMG, and invasive EEG. Neurology 2004;63:2153–2154.CrossRefGoogle ScholarPubMed
Walczak, T, Papcostas, S, Williams, D, Scheuer, M, Notarfanscesco, A. Outcome after diagnosis of psychogenic nonepileptic seizures. Epilepsia 1995;36:1131–1137.CrossRefGoogle ScholarPubMed
Jones, SG, O'Brien, TJ, Adams, SJ, et al. Clinical characteristics and outcome in patients with psychogenic nonepileptic seizures. Psychosom Med 2010;72:487–497.Google Scholar
Mayor, R, Howlett, S, Grunewald, R, Reuber, M. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization. Epilepsia 2010;51:1169–1176.Google Scholar
LaFrance, WC, Baird, GL, Barry, JJ, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014;71:997–1005.Google Scholar
Martlew, J, Pulman, J, Marson, AG. Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev 2014; 2:CD006370.Google Scholar
Conwill, M, Oakley, L, Evans, K, Cavanna, AE. CBT-based group therapy intervention for nonepileptic attacks and other functional neurological symptoms: a pilot study. Epilepsy Behav 2014;34:68–72.Google Scholar
Goldstein, LH, Chalder, T, Chigwedere, C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology 2010;74:1986–1994.Google Scholar
Mayor, R, Brown, RJ, Cock, H, et al. Short-term outcome of psychogenic non-epileptic seizures after communication of the diagnosis. Epilepsy Behav 2012;25:676–681.Google Scholar
Duncan, R. Psychogenic nonepileptic seizures: diagnosis and initial management. Expert Rev Neurother 2010;1012:1803–1809.Google Scholar
Hall-Patch, L, Brown, R, House, A, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia 2010;51:70–78.Google Scholar
McKenzie, P, Oto, M, Russell, A, Pelosi, A, Duncan, R. Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks. Neurology 2010;74:64–69.Google Scholar
Seneviratne, U, Briggs, B, Lowenstern, D, D'Souza, W. The spectrum of psychogenic non-epileptic seizures and comorbidities seen in an epilepsy monitoring unit. J Clin Neurosci 2011;18:361–363.Google Scholar
Bodde, NM, van der Kruijs, SJ, Ijff, DM, et al. Subgroup classification in patients with psychogenic non-epileptic seizures. Epilepsy Behav 2013;26:279–289.Google Scholar
Alessi, R, Valente, KD. Psychogenic non-epileptic seizures at a tertiary care center in Brazil. Epilepsy Behav 2013;26:91–95.CrossRefGoogle Scholar
An, DM, Wu, XT, Yan, B, Mu, J, Zhou, D. Clinical features of psychogenic nonepileptic seizures: a study of 64 cases in southwest China. Epilepsy Behav 2010;17:408–411.Google Scholar
Hubsch, C, Baumann, C, Hingray, C, et al. Clinical classification of psychogenic non-epileptic seizures based on video-EEG analysis and automatic clustering. J Neurol Neurosurg Psychiatry 2011;82:955–960.Google Scholar
Dhiman, V, Sinha, S, Rawat, VS, et al. Semiological characteristics of adults with psychogenic nonepileptic seizures (PNESs): an attempt towards a new classification. Epilepsy Behav 2013;27:427–432.Google Scholar
Asadi-Pooya, AA, Emami, Y, Emami, M, Sperling, MR. Prolonged psychogenic nonepileptic seizures or pseudostatus. Epilepsy Behav 2014;31:304–306.Google Scholar
Magaudda, A, Gugliotta, SC, Tallarico, R, et al. Identification of three distinct groups of patients with both epilepsy and psychogenic nonepileptic seizures. Epilepsy Behav 2011;22:318–323.Google Scholar
LaFrance, WC, Miller, IW, Ryan, CE, et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav 2009;14:591–596.Google Scholar
Noe, KH, Grade, M, Stonnington, CM, Driver-Dunckley, E, Locke, DE. Confirming psychogenic nonepileptic seizures with video-EEG: sex matters. Epilepsy Behav 2012;23:220–223.Google Scholar
Strutt, AM, Hill, SW, Scott, BM, Uber-Zak, L, Fogel, TG. A comprehensive neuropsychological profile of women with psychogenic nonepileptic seizures. Epilepsy Behav 2011;20:24–28.Google Scholar
Asadi-Pooya, AA, Emami, M, Emami, Y. Ictal injury in psychogenic non-epileptic seizures. Seizure 2014;23:363–366.Google Scholar
Myers, L, Fleming, M, Lancman, M, Perrine, K, Lancman, M. Stress coping strategies in patients with psychogenic non-epileptic seizures and how they relate to trauma symptoms, alexithymia, anger and mood. Seizure 2013;22:634–639.Google Scholar
LaFrance, WC, Keitner, GI, Papandonatos, GD, et al. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology 2010;75:1166–1173.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×